Article Text

Download PDFPDF
CASE REPORT
Rifampicin: not always an innocent drug
  1. Dafni Sveroni1,
  2. Aggelos Stefos1,
  3. Eirini I Rigopoulou1,2 and
  4. Georgios N Dalekos1,2
  1. 1 Department of Medicine and Research Laboratory of Internal Medicine, University Hospital of Larissa, Larissa, Greece
  2. 2 Institute of Internal Medicine and Hepatology, Larissa, Greece
  1. Correspondence to Professor Georgios N Dalekos, dalekos{at}med.uth.gr

Footnotes

  • Patient consent for publication Obtained.

  • Contributors GND and EIR were the principal treating physicians, had the original idea and designed the study. DS and AS collected and summarised the published literature and the data of the patient. DS, AS and EIR wrote the first draft of the manuscript. GND made the final critical revision of the manuscript for important intellectual content. All authors have seen and approved the final version of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Patient consent for publication Obtained.

  • Contributors GND and EIR were the principal treating physicians, had the original idea and designed the study. DS and AS collected and summarised the published literature and the data of the patient. DS, AS and EIR wrote the first draft of the manuscript. GND made the final critical revision of the manuscript for important intellectual content. All authors have seen and approved the final version of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.